跳至主要内容
临床试验/NCT04669756
NCT04669756已完成不适用

Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary

University Hospital Muenster1 个研究点 分布在 1 个国家目标入组 409 人开始时间: 2018年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
409
试验地点
1
主要终点
prevalence of postoperative ovarian adhesions

研究概览

简要总结

prospective randomized Trial comparing ovariopexy over 2, 4 or 6 days vs Placebo after surgery because of endometriosis of the pelvic side wall or the ovary or both

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •premenopausal
  • •wants to participate
  • •removal of endometriosis of the pelvic side wall or ovary

排除标准

  • •postmenopausal
  • •cannot give informed consent
  • •no endometriosis during Operation
  • •no Opening of pelvic side wall or ovary during the Operation
  • •breast feeding

研究组 & 干预措施

A

Experimental

ovariopexy for 2 days

干预措施: ovariopexy (Procedure)

B

Experimental

ovariopexy for 4 days

干预措施: ovariopexy (Procedure)

C

Experimental

ovariopexy for 6 days

干预措施: ovariopexy (Procedure)

D

Placebo Comparator

Placebo Operation for 2 days

干预措施: placebo operation (Procedure)

结局指标

主要结局

prevalence of postoperative ovarian adhesions

时间窗: 3 months after operation

prevalence of postoperative ovarian adhesions

次要结局

  • postoperative pain(daily during postoperative hospitalisation and at follow up visit after 3 months)
  • postoperative infectious complications(up to 3 months after operation)
  • AMH(at follow up visit after 3 months)

研究者

发起方
University Hospital Muenster
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. med. Sebastian Daniel Schäfer

Head of Gynecology

University Hospital Muenster

研究点 (1)

Loading locations...

相似试验